Cargando…
The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours
BACKGROUND: The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was established to advance precision oncology in Ho...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398587/ https://www.ncbi.nlm.nih.gov/pubmed/37547050 http://dx.doi.org/10.1016/j.lanwpc.2023.100775 |
_version_ | 1785084084814348288 |
---|---|
author | El Helali, Aya Lam, Tai-Chung Ko, Elaine Yee-Ling Shih, David J.H. Chan, Chun Kau Wong, Charlene H.L. Wong, Jason W.H. Cheung, Lydia W.T. Lau, Johnny K.S. Liu, Anthony P.Y. Chan, Ann S.Y. Loong, Herbert H. Lam, Stephen Tak Sum Chan, Godfrey Chi-Fung Lee, Victor H.F. Yuen, Kwok Keung Ng, Wai-Tong Lee, Anne W.M. Ma, Edmond S.K. |
author_facet | El Helali, Aya Lam, Tai-Chung Ko, Elaine Yee-Ling Shih, David J.H. Chan, Chun Kau Wong, Charlene H.L. Wong, Jason W.H. Cheung, Lydia W.T. Lau, Johnny K.S. Liu, Anthony P.Y. Chan, Ann S.Y. Loong, Herbert H. Lam, Stephen Tak Sum Chan, Godfrey Chi-Fung Lee, Victor H.F. Yuen, Kwok Keung Ng, Wai-Tong Lee, Anne W.M. Ma, Edmond S.K. |
author_sort | El Helali, Aya |
collection | PubMed |
description | BACKGROUND: The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was established to advance precision oncology in Hong Kong. A multicenter retrospective study investigated the feasibility of the HKU-HKSH MTB in determining genome-guided therapy for treatment-refractory solid cancers in Hong Kong. METHODS: Patients who were presented at the HKU-HKSH MTB between August 2018 and June 2022 were included in this study. The primary study endpoints were the proportion of patients who receive MTB-guided therapy based on genomic analysis and overall survival (OS). Secondary endpoints included the proportion of patients with actionable genomic alterations, objective response rate (ORR), and disease control rate (DCR). The Kaplan–Meier method was used in the survival analyses, and hazard ratios were calculated using univariate Cox regression. FINDINGS: 122 patients were reviewed at the HKU-HKSH MTB, and 63% (n = 77) adopted treatment per the MTB recommendations. These patients achieved a significantly longer median OS than those who did not receive MTB-guided therapy (12.7 months vs. 5.2 months, P = 0.0073). Their ORR and DCR were 29% and 65%, respectively. INTERPRETATION: Our study demonstrated that among patients with heavily pre-treated advanced solid cancers, MTB-guided treatment could positively impact survival outcomes, thus illustrating the applicability of NGS CGPs in real-world clinical practice. FUNDING: The study was supported by the 10.13039/100007422Li Shu Pui Medical Foundation. Dr Aya El Helali was supported by the Li Shu Pui Medical Foundation Fellowship grant from the Li Shu Pui Medical Foundation. Funders had no role in study design, data collection, data analysis, interpretation, or writing of the report. |
format | Online Article Text |
id | pubmed-10398587 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-103985872023-08-04 The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours El Helali, Aya Lam, Tai-Chung Ko, Elaine Yee-Ling Shih, David J.H. Chan, Chun Kau Wong, Charlene H.L. Wong, Jason W.H. Cheung, Lydia W.T. Lau, Johnny K.S. Liu, Anthony P.Y. Chan, Ann S.Y. Loong, Herbert H. Lam, Stephen Tak Sum Chan, Godfrey Chi-Fung Lee, Victor H.F. Yuen, Kwok Keung Ng, Wai-Tong Lee, Anne W.M. Ma, Edmond S.K. Lancet Reg Health West Pac Articles BACKGROUND: The integration of next-generation sequencing (NGS) comprehensive gene profiling (CGP) into clinical practice is playing an increasingly important role in oncology. Therefore, the HKU-HKSH Multi-disciplinary Molecular Tumour Board (MTB) was established to advance precision oncology in Hong Kong. A multicenter retrospective study investigated the feasibility of the HKU-HKSH MTB in determining genome-guided therapy for treatment-refractory solid cancers in Hong Kong. METHODS: Patients who were presented at the HKU-HKSH MTB between August 2018 and June 2022 were included in this study. The primary study endpoints were the proportion of patients who receive MTB-guided therapy based on genomic analysis and overall survival (OS). Secondary endpoints included the proportion of patients with actionable genomic alterations, objective response rate (ORR), and disease control rate (DCR). The Kaplan–Meier method was used in the survival analyses, and hazard ratios were calculated using univariate Cox regression. FINDINGS: 122 patients were reviewed at the HKU-HKSH MTB, and 63% (n = 77) adopted treatment per the MTB recommendations. These patients achieved a significantly longer median OS than those who did not receive MTB-guided therapy (12.7 months vs. 5.2 months, P = 0.0073). Their ORR and DCR were 29% and 65%, respectively. INTERPRETATION: Our study demonstrated that among patients with heavily pre-treated advanced solid cancers, MTB-guided treatment could positively impact survival outcomes, thus illustrating the applicability of NGS CGPs in real-world clinical practice. FUNDING: The study was supported by the 10.13039/100007422Li Shu Pui Medical Foundation. Dr Aya El Helali was supported by the Li Shu Pui Medical Foundation Fellowship grant from the Li Shu Pui Medical Foundation. Funders had no role in study design, data collection, data analysis, interpretation, or writing of the report. Elsevier 2023-04-28 /pmc/articles/PMC10398587/ /pubmed/37547050 http://dx.doi.org/10.1016/j.lanwpc.2023.100775 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Articles El Helali, Aya Lam, Tai-Chung Ko, Elaine Yee-Ling Shih, David J.H. Chan, Chun Kau Wong, Charlene H.L. Wong, Jason W.H. Cheung, Lydia W.T. Lau, Johnny K.S. Liu, Anthony P.Y. Chan, Ann S.Y. Loong, Herbert H. Lam, Stephen Tak Sum Chan, Godfrey Chi-Fung Lee, Victor H.F. Yuen, Kwok Keung Ng, Wai-Tong Lee, Anne W.M. Ma, Edmond S.K. The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title | The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title_full | The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title_fullStr | The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title_full_unstemmed | The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title_short | The impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
title_sort | impact of the multi-disciplinary molecular tumour board and integrative next generation sequencing on clinical outcomes in advanced solid tumours |
topic | Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398587/ https://www.ncbi.nlm.nih.gov/pubmed/37547050 http://dx.doi.org/10.1016/j.lanwpc.2023.100775 |
work_keys_str_mv | AT elhelaliaya theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT lamtaichung theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT koelaineyeeling theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT shihdavidjh theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT chanchunkau theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT wongcharlenehl theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT wongjasonwh theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT cheunglydiawt theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT laujohnnyks theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT liuanthonypy theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT chanannsy theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT loongherberth theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT lamstephentaksum theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT changodfreychifung theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT leevictorhf theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT yuenkwokkeung theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT ngwaitong theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT leeannewm theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT maedmondsk theimpactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT elhelaliaya impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT lamtaichung impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT koelaineyeeling impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT shihdavidjh impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT chanchunkau impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT wongcharlenehl impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT wongjasonwh impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT cheunglydiawt impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT laujohnnyks impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT liuanthonypy impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT chanannsy impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT loongherberth impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT lamstephentaksum impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT changodfreychifung impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT leevictorhf impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT yuenkwokkeung impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT ngwaitong impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT leeannewm impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours AT maedmondsk impactofthemultidisciplinarymoleculartumourboardandintegrativenextgenerationsequencingonclinicaloutcomesinadvancedsolidtumours |